HEADER STRUCTURAL PROTEIN 15-APR-19 6JUT TITLE CRYSTAL STRUCTURE OF ZAK IN COMPLEX WITH COMPOUND 6K COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.11.25; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ZAK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS ZAK, INHIBITOR, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.L.KONG,C.H.YUN REVDAT 3 22-NOV-23 6JUT 1 REMARK REVDAT 2 25-MAR-20 6JUT 1 JRNL REVDAT 1 24-JUL-19 6JUT 0 JRNL AUTH J.YANG,M.A.SHIBU,L.KONG,J.LUO,F.BADREALAMKHAN,Y.HUANG, JRNL AUTH 2 Z.C.TU,C.H.YUN,C.Y.HUANG,K.DING,X.LU JRNL TITL DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF JRNL TITL 2 1,2,3-TRIAZOLE BENZENESULFONAMIDES AS NEW SELECTIVE JRNL TITL 3 LEUCINE-ZIPPER AND STERILE-ALPHA MOTIF KINASE (ZAK) JRNL TITL 4 INHIBITORS. JRNL REF J.MED.CHEM. V. 63 2114 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31244114 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00664 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 15935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 814 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 3.7235 0.97 2581 167 0.1583 0.1898 REMARK 3 2 3.7235 - 2.9556 0.99 2580 120 0.1763 0.2132 REMARK 3 3 2.9556 - 2.5820 0.98 2576 125 0.1858 0.2111 REMARK 3 4 2.5820 - 2.3460 0.98 2530 133 0.1942 0.2584 REMARK 3 5 2.3460 - 2.1778 0.98 2527 135 0.2086 0.3219 REMARK 3 6 2.1778 - 2.1000 0.91 2327 134 0.2298 0.3152 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2465 REMARK 3 ANGLE : 0.860 3341 REMARK 3 CHIRALITY : 0.051 363 REMARK 3 PLANARITY : 0.006 420 REMARK 3 DIHEDRAL : 15.833 1464 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-APR-19. REMARK 100 THE DEPOSITION ID IS D_1300011793. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15935 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5X5O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 5.5, 25% PEG3350, REMARK 280 0.2M NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.96600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.59350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.96600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.59350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ALA A 1 REMARK 465 MET A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 GLY A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 GLU A 305 REMARK 465 GLN A 306 REMARK 465 GLU A 307 REMARK 465 LEU A 308 REMARK 465 LYS A 309 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 14 CG OD1 OD2 REMARK 470 PHE A 27 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 233 NH1 NH2 REMARK 470 GLU A 237 CG CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 SER A 302 OG REMARK 470 PHE A 303 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 304 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 100 NH2 ARG A 156 1554 1.07 REMARK 500 CD GLU A 100 NH2 ARG A 156 1554 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 26 74.33 45.00 REMARK 500 LYS A 49 147.11 -170.54 REMARK 500 ASN A 95 39.71 -87.31 REMARK 500 ARG A 132 -5.87 73.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C9O A 401 DBREF 6JUT A 5 309 UNP Q9NYL2 MLTK_HUMAN 5 309 SEQADV 6JUT GLY A 0 UNP Q9NYL2 EXPRESSION TAG SEQADV 6JUT ALA A 1 UNP Q9NYL2 EXPRESSION TAG SEQADV 6JUT MET A 2 UNP Q9NYL2 EXPRESSION TAG SEQADV 6JUT GLY A 3 UNP Q9NYL2 EXPRESSION TAG SEQADV 6JUT SER A 4 UNP Q9NYL2 EXPRESSION TAG SEQRES 1 A 310 GLY ALA MET GLY SER GLY ALA SER PHE VAL GLN ILE LYS SEQRES 2 A 310 PHE ASP ASP LEU GLN PHE PHE GLU ASN CYS GLY GLY GLY SEQRES 3 A 310 SER PHE GLY SER VAL TYR ARG ALA LYS TRP ILE SER GLN SEQRES 4 A 310 ASP LYS GLU VAL ALA VAL LYS LYS LEU LEU LYS ILE GLU SEQRES 5 A 310 LYS GLU ALA GLU ILE LEU SER VAL LEU SER HIS ARG ASN SEQRES 6 A 310 ILE ILE GLN PHE TYR GLY VAL ILE LEU GLU PRO PRO ASN SEQRES 7 A 310 TYR GLY ILE VAL THR GLU TYR ALA SER LEU GLY SER LEU SEQRES 8 A 310 TYR ASP TYR ILE ASN SER ASN ARG SER GLU GLU MET ASP SEQRES 9 A 310 MET ASP HIS ILE MET THR TRP ALA THR ASP VAL ALA LYS SEQRES 10 A 310 GLY MET HIS TYR LEU HIS MET GLU ALA PRO VAL LYS VAL SEQRES 11 A 310 ILE HIS ARG ASP LEU LYS SER ARG ASN VAL VAL ILE ALA SEQRES 12 A 310 ALA ASP GLY VAL LEU LYS ILE CYS ASP PHE GLY ALA SER SEQRES 13 A 310 ARG PHE HIS ASN HIS THR THR HIS MET SER LEU VAL GLY SEQRES 14 A 310 THR PHE PRO TRP MET ALA PRO GLU VAL ILE GLN SER LEU SEQRES 15 A 310 PRO VAL SER GLU THR CYS ASP THR TYR SER TYR GLY VAL SEQRES 16 A 310 VAL LEU TRP GLU MET LEU THR ARG GLU VAL PRO PHE LYS SEQRES 17 A 310 GLY LEU GLU GLY LEU GLN VAL ALA TRP LEU VAL VAL GLU SEQRES 18 A 310 LYS ASN GLU ARG LEU THR ILE PRO SER SER CYS PRO ARG SEQRES 19 A 310 SER PHE ALA GLU LEU LEU HIS GLN CYS TRP GLU ALA ASP SEQRES 20 A 310 ALA LYS LYS ARG PRO SER PHE LYS GLN ILE ILE SER ILE SEQRES 21 A 310 LEU GLU SER MET SER ASN ASP THR SER LEU PRO ASP LYS SEQRES 22 A 310 CYS ASN SER PHE LEU HIS ASN LYS ALA GLU TRP ARG CYS SEQRES 23 A 310 GLU ILE GLU ALA THR LEU GLU ARG LEU LYS LYS LEU GLU SEQRES 24 A 310 ARG ASP LEU SER PHE LYS GLU GLN GLU LEU LYS HET C9O A 401 35 HETNAM C9O ~{N}-[2,4-BIS(FLUORANYL)-3-[4-(3-METHOXY-1~{H}- HETNAM 2 C9O PYRAZOLO[3,4-B]PYRIDIN-5-YL)-1,2,3-TRIAZOL-1- HETNAM 3 C9O YL]PHENYL]-3-BROMANYL-BENZENESULFONAMIDE FORMUL 2 C9O C21 H14 BR F2 N7 O3 S FORMUL 3 HOH *116(H2 O) HELIX 1 AA1 LYS A 12 ASP A 14 5 3 HELIX 2 AA2 GLU A 51 SER A 58 1 8 HELIX 3 AA3 SER A 89 ASN A 95 1 7 HELIX 4 AA4 SER A 96 MET A 102 5 7 HELIX 5 AA5 ASP A 103 GLU A 124 1 22 HELIX 6 AA6 LYS A 135 ARG A 137 5 3 HELIX 7 AA7 GLY A 153 HIS A 158 1 6 HELIX 8 AA8 THR A 162 VAL A 167 1 6 HELIX 9 AA9 THR A 169 MET A 173 5 5 HELIX 10 AB1 ALA A 174 GLN A 179 1 6 HELIX 11 AB2 THR A 186 ARG A 202 1 17 HELIX 12 AB3 GLU A 210 GLU A 220 1 11 HELIX 13 AB4 PRO A 232 TRP A 243 1 12 HELIX 14 AB5 ASP A 246 ARG A 250 5 5 HELIX 15 AB6 SER A 252 SER A 264 1 13 HELIX 16 AB7 SER A 268 HIS A 278 1 11 HELIX 17 AB8 ASN A 279 LYS A 304 1 26 SHEET 1 AA1 6 GLN A 10 ILE A 11 0 SHEET 2 AA1 6 PHE A 68 GLU A 74 1 O VAL A 71 N ILE A 11 SHEET 3 AA1 6 ASN A 77 GLU A 83 -1 O VAL A 81 N GLY A 70 SHEET 4 AA1 6 LYS A 40 LEU A 47 -1 N LYS A 45 O ILE A 80 SHEET 5 AA1 6 VAL A 30 TRP A 35 -1 N TRP A 35 O LYS A 40 SHEET 6 AA1 6 LEU A 16 ASN A 21 -1 N GLN A 17 O LYS A 34 SHEET 1 AA2 2 VAL A 139 ILE A 141 0 SHEET 2 AA2 2 LEU A 147 ILE A 149 -1 O LYS A 148 N VAL A 140 CISPEP 1 PRO A 75 PRO A 76 0 1.34 SITE 1 AC1 19 CYS A 22 VAL A 30 ALA A 43 LYS A 45 SITE 2 AC1 19 ALA A 54 SER A 58 PHE A 68 ILE A 80 SITE 3 AC1 19 THR A 82 TYR A 84 ALA A 85 GLY A 88 SITE 4 AC1 19 CYS A 150 ASP A 151 PHE A 152 GLY A 153 SITE 5 AC1 19 PHE A 157 HOH A 503 HOH A 588 CRYST1 129.932 49.187 42.973 90.00 107.24 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007696 0.000000 0.002388 0.00000 SCALE2 0.000000 0.020331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024364 0.00000